Last August 15 in Goettingen, Germany, The District Institute of Science, Biotechnology and Innovation in Health (IDCBIS) and the German Primate Center (DPZ), headed by Dr. Jens Grube, signed a scientific cooperation agreement that will extend until April of the year 2019.
Gustavo Salguero MD. PhD., Research Leader of the Cell Therapy Unit, was the delegate for the IDCBIS to sign the agreement and on behalf of the DPZ attended Dr. Jens Gruber, and Dr. Manfred Eberle, the event was attended by the Ambassador María Lorena Gutiérrez and the embassy work team.
Colciencias was the mediating entity for the scientific cooperation process, through the annual call for binational mobility of researchers and the Federal Ministry of Education and Research of Germany (BMBF).
This agreement was developed jointly by the DPZ and the IDCBIS, with the aim of joining forces for the generation and transfer of knowledge and technology, as well as to investigate and implement new therapeutic strategies that combine stem cells and technologies of genetic modification or gene therapy.
“The institutions expressed the interest of cooperating in the exchange of knowledge, exchange of personnel and joint research projects that ultimately lead to publishable data and advances in technological development. According to the signed document, the parties agree to transfer knowledge in terms of staff training to establish analytical workflows and techniques that involve next-generation cell biochemistry or in-depth sequencing (NGS), and genetic manipulation and NGS data analysis. The IDCBIS will provide knowledge about the biology of human stem cells and their specific applications as therapeutic tools for immunotherapy and regeneration. “Colciencias assured the Department of Science, Technology and Innovation.
This first agreement is part of the IDCBIS projection at national and international level as a center of excellence in biomedical sciences research and health biotechnology.
More information in: